Safety and Efficacy Study of the Cyclooxygenase-2 Inhibitor Parecoxib Sodium Applied for Postoperative Analgesia After Endo-Nasal Operation.

about

Parecoxib prevents complications in hepatocellular carcinoma patients receiving hepatic transarterial chemoembolization: a prospective score-matched cohort study.

P2860

Q40110698-62BF8589-36B2-44E7-8510-DD15DF4E2F22

P2860

Safety and Efficacy Study of the Cyclooxygenase-2 Inhibitor Parecoxib Sodium Applied for Postoperative Analgesia After Endo-Nasal Operation.

Item

http://www.wikidata.org/entity/Q47723616

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Safety and Efficacy Study of t ...... ia After Endo-Nasal Operation.

@en

Safety and Efficacy Study of t ...... ia After Endo-Nasal Operation.

@nl

type

Item

label

Safety and Efficacy Study of t ...... ia After Endo-Nasal Operation.

@en

Safety and Efficacy Study of t ...... ia After Endo-Nasal Operation.

@nl

prefLabel

Safety and Efficacy Study of t ...... ia After Endo-Nasal Operation.

@en

Safety and Efficacy Study of t ...... ia After Endo-Nasal Operation.

@nl

P1476

Safety and Efficacy Study of t ...... ia After Endo-Nasal Operation.

@en

P2093

Ailin Luo

http://www.w3.org/2001/XMLSchema#string

Hong Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery.

A pharmacokinetic study of intramuscular (i.m.) parecoxib sodium in normal subjects.

Effects of parecoxib, a parenteral COX-2-specific inhibitor, on the pharmacokinetics and pharmacodynamics of propofol.

The injectable cyclooxygenase-2-specific inhibitor parecoxib sodium has analgesic efficacy when administered preoperatively.

Efficacy and safety of intravenous parecoxib sodium in relieving acute postoperative pain following gynecologic laparotomy surgery.

Analgesic effects of parecoxib following total abdominal hysterectomy.

Simultaneous assessment of drug interactions with low- and high-extraction opioids: application to parecoxib effects on the pharmacokinetics and pharmacodynamics of fentanyl and alfentanil.

Comparison of parecoxib and proparacetamol in endoscopic nasal surgery patients.

The cyclooxygenase-2-specific inhibitor parecoxib sodium is as effective as 12 mg of morphine administered intramuscularly for treating pain after gynecologic laparotomy surgery.

Parecoxib sodium, a parenteral cyclooxygenase 2 selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplasty.

P304

467-472

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/PAPR.12294

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25857847

http://www.w3.org/2001/XMLSchema#string

Safety and Efficacy Study of the Cyclooxygenase-2 Inhibitor Parecoxib Sodium Applied for Postoperative Analgesia After Endo-Nasal Operation.

about

P2860

P2860

Safety and Efficacy Study of the Cyclooxygenase-2 Inhibitor Parecoxib Sodium Applied for Postoperative Analgesia After Endo-Nasal Operation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698